Cirtuvivint

A Phase I Study Evaluating the Safety of Cirtuvivint as Monotherapy and in Combination With ASTX727 and ASTX727 + Venetoclax in Patients With Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)

Near Add Your Location

Sorting 16 by

Center of Excellence

Memorial Sloan Kettering Cancer Center
New York, NY
  • Accepting patients
  • Show Principal Investigator

Center of Excellence

Smilow Cancer Hospital at Yale New Haven
New Haven, CT
  • Accepting patients

Center of Excellence

University of Chicago Medicine
Comprehensive Cancer Center
Chicago, IL
  • Accepting patients

Center of Excellence

University of Maryland Medical Center
Marlene and Stewart Greenebaum Comprehensive Cancer Center
Baltimore, MD
  • Accepting patients
Memorial Sloan Kettering Westchester
West Harrison, NY
  • Accepting patients
  • Show Principal Investigator
Memorial Sloan Kettering Bergen
Montvale, NJ
  • Accepting patients
  • Show Principal Investigator

Center of Excellence

Dana-Farber Cancer Institute
Boston, MA
  • Accepting patients

Center of Excellence

Winship Cancer Institute
Emory University
Atlanta, GA
  • Accepting patients
Memorial Sloan Kettering Monmouth
Middletown, NJ
  • Accepting patients
  • Show Principal Investigator

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 803-1766

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.